S0X9, prostaglandin D2 and retinoic acid for treating pigmentary conditions and melanoma

Details for Australian Patent Application No. 2008360658 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Hearing, Vincent J.; Passeron, Thierry

Agent Davies Collison Cave

Pub. Number AU-A-2008360658

PCT Pub. Number WO2010/019120

Filing date 15 August 2008

Wipo publication date 18 February 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/019120 Priority application(s): WO2010/019120

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008360689-A portable table

2008360649-An air pump producing high pressure